Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Verrica Pharmaceuticals Inc (NQ: VRCA )

12.05 USD UNCHANGED
Streaming Delayed Price Updated: 4:20 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Verrica Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 Next >
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Conta
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. 
From Business Wire News Releases
VRCA Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Verrica Pharmaceuticals Inc. (“Verrica” or "the Company") (NASDAQ: VRCA) and certain of its... 
From Business Wire News Releases
Lead Plaintiff Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm
From NewMediaWire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Verrica Pharmaceuticals Inc. 
From Business Wire News Releases
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GEO Group, Wirecard, J2 Global, and Verrica Pharmaceuticals and Encourages Investors to Contact the Fir
From GlobeNewswire News Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Verrica Pharmaceuticals Inc. (VRCA) Investors 
From Business Wire News Releases
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Verrica Pharmaceuticals Inc. To Contact The Firm
From GlobeNewswire News Releases
VERRICA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Eastern District of... 
From Business Wire News Releases
Portnoy Law: Lawsuit Filed On Behalf of Verrica Pharmaceuticals Inc. Investors
Investors with losses of $100,000 or more are encouraged to contact the firm 
From GlobeNewswire News Releases
The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)
The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Eastern District of Pennsylvania captioned Potter v. Verrica... 
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
From GlobeNewswire News Releases
VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc.
VRCA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Verrica Pharmaceuticals Inc. 
From Business Wire News Releases
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers INmune Bio, Inc. (NASDAQ: INMB) shares jumped 167.1% to $23.64 following a positive clinical readout from the company. ... 
Tags HMY Benzinga UMRX
From Benzinga
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BPMC GRTX IBB
From Benzinga
Verrica Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
From GlobeNewswire News Releases
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news emerging out of the sector. FDA approved a few drugs, including Endo International PLC's cellulite treatment, while Merck & Co. & Eisai... 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector. FDA approved a few drugs, ... 
Tags ABT Earnings GSK
From Benzinga
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
From GlobeNewswire News Releases
The Law Offices of Frank R. Cruz Continues Its Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
The Law Offices of Frank R. Cruz continues its investigation on behalf of Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) investors concerning the Company and its officers’... 
From Business Wire News Releases
66 Biggest Movers From Yesterday
Gainers National General Holdings Corp. (NASDAQ: NGHC) shares jumped 65.8% to close at $33.84 on Wednesday after Allstate ... 
Tags Market News HOFV RUHN
From Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Verrica Pharmaceuticals Inc. on Behalf of Investors 
From Business Wire News Releases
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors 
From Business Wire News Releases
Shareholder Alert: Robbins LLP Announces It Is Investigating the Officers and Directors of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Shareholders
Shareholder rights law firm Robbins LLP announces it is investigating whether certain officers and directors of Verrica Pharmaceuticals Inc. (NYSE: VRCA) violated federal securities laws. Verrica is a... 
From Business Wire News Releases
VRCA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Verrica Pharmaceuticals Inc. and Encourages Investors to Contact the Firm
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Verrica Pharmaceuticals Inc. ("Verrica" or "the Company") (NASDAQ: VRCA).... 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verrica Pharmaceuticals Inc. - VRCA
Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular ... 
Tags ALXN FDA ENDP
From Benzinga
40 Stocks Moving in Wednesday's Pre-Market Session
Gainers MYOS RENS Technology Inc. (NASDAQ: MYOS) rose 122.6% to $1.97 in pre-market trading after the company reported merger and ... 
Tags CRMD Premarket Movers OXBR
From Benzinga
65 Biggest Movers From Yesterday
Gainers Polar Power, Inc. (NASDAQ: POLA) shares surged 262% to close at $4.96 on Tuesday after jumping around 9% on ... 
Tags CGA Specialty Chemicals CPST
From Benzinga
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. (VRCA) on Behalf of Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Verrica Pharmaceuticals Inc. on Behalf of Investors 
From Business Wire News Releases
The Law Offices of Frank R. Cruz Announces Investigation on Behalf of Verrica Pharmaceuticals Inc. Investors (VRCA)
The Law Offices of Frank R. Cruz announces an investigation on behalf of Verrica Pharmaceuticals Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) investors concerning the Company and its officers’... 
From Business Wire News Releases
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.